| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 496 | 2024 |
| Global Burden of Cardiovascular Diseases and Risks, 1990-2022 1990-2022 Mensah, G, Fuster, V, Murray, C. et al. Global Burden of ... J Am Coll Cardiol 82 (25), 2350–2473, 2023 | 492 | 2023 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 465 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 444 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 297 | 2024 |
| MiRNA and LncRNA as potential biomarkers in triple-negative breast cancer: a review SR Volovat, C Volovat, I Hordila, DA Hordila, CC Mirestean, OT Miron, ... Frontiers in oncology 10, 526850, 2020 | 113 | 2020 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The lancet 403 (10440), 2057-2099, 2024 | 89 | 2024 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 88 | 2024 |
| The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease … PCC GBD 2019 Lip, Oral JAMA Oncology 9 (10), 1321-1467, 2023 | 61* | 2023 |
| Targeting CDK4/6 pathways and beyond in breast cancer D Ribnikar, SR Volovat, F Cardoso The Breast 43, 8-17, 2019 | 38 | 2019 |
| Changes in the histological spectrum of glomerular diseases in the past 16 years in the North-Eastern region of Romania C Volovăt, I Cãruntu, C Costin, A Stefan, R Popa, S Volovăt, D Siriopol, ... BMC nephrology 14, 1-7, 2013 | 30 | 2013 |
| Nephrotoxicity/renal failure after therapy with 90Yttrium-and 177Lutetium-radiolabeled somatostatin analogs in different types of neuroendocrine tumors: A systematic review CR Stolniceanu, I Nistor, SC Bilha, V Constantin, V Simona, M Matovic, ... Nuclear medicine communications 41 (7), 601-617, 2020 | 28 | 2020 |
| Second-line chemotherapy with gemcitabine and oxaliplatin in combination with loco-regional hyperthermia (EHY-2000) in patients with refractory metastatic pancreatic cancer … C Volovat, SR Volovat, V Scripcaru, L Miron Romanian Reports in Physics 66 (1), 166-174, 2014 | 28 | 2014 |
| A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer SR Volovat, TE Ciuleanu, P Koralewski, JEG Olson, A Croitoru, K Koynov, ... Oncotarget 11 (33), 3105, 2020 | 23 | 2020 |
| Oncolytic virotherapy: A new paradigm in cancer immunotherapy SR Volovat, DV Scripcariu, IA Vasilache, CR Stolniceanu, C Volovat, ... International journal of molecular sciences 25 (2), 1180, 2024 | 22 | 2024 |
| Landscape of immunotherapy options for colorectal cancer: current knowledge and future perspectives beyond immune checkpoint blockade A Gorzo, D Galos, SR Volovat, CV Lungulescu, C Burz, D Sur Life 12 (2), 229, 2022 | 21 | 2022 |
| Evaluation of cumulative effects of chemotherapy and bevacizumab (avastin) in oncological patients with periodontal disease D Nitescu, C Mihai, C Oanta Rev. Chim.(Bucharest) 68, 549, 2017 | 21 | 2017 |
| Cardioprotective apelin effects and the cardiac-renal axis: review of existing science and potential therapeutic applications of synthetic and native regulated apelin C Ureche, L Tapoi, S Volovat, L Voroneanu, M Kanbay, A Covic Journal of Human Hypertension 33 (6), 429-435, 2019 | 19 | 2019 |
| Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease … D Bryazka, MB Reitsma, YH Abate, AHA Abd Al Magied, A Abdelkader, ... The lancet Public health 9 (10), e729-e744, 2024 | 18 | 2024 |
| The results of combination of ifosfamid and locoregional hyperthermia (EHY 2000) in patients with advanced abdominal soft-tissue sarcoma after relapse of first line chemotherapy SR Volovat, C Volovat, V Scripcaru, L Miron, C Lupascu Romanian Reports in Physics 66 (1), 175-181, 2014 | 18 | 2014 |
